Study Analyzing the Effect of Rifampicin Administration on the Pharmacokinetics of Neramexane Mesylate

NCT00955760 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Neramexane

Sponsor

Merz Pharmaceuticals GmbH